"Torsades de Pointes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.
| Descriptor ID |
D016171
|
| MeSH Number(s) |
C14.280.067.845.940.700 C14.280.123.875.940.700 C23.550.073.845.940.700
|
| Concept/Terms |
Torsades de Pointes- Torsades de Pointes
- Pointes, Torsades de
- de Pointes, Torsades
- Torsade de Pointes
- Pointes, Torsade de
- de Pointes, Torsade
|
Below are MeSH descriptors whose meaning is more general than "Torsades de Pointes".
Below are MeSH descriptors whose meaning is more specific than "Torsades de Pointes".
This graph shows the total number of publications written about "Torsades de Pointes" by people in this website by year, and whether "Torsades de Pointes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 4 | 5 | 9 |
| 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Torsades de Pointes" by people in Profiles.
-
Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey. Int J Clin Pract. 2021 Jul; 75(7):e14182.
-
Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. BMJ Case Rep. 2021 Mar 24; 14(3).
-
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions. Am J Emerg Med. 2021 10; 48:363-364.
-
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review. Psychopharmacology (Berl). 2021 Feb; 238(2):329-340.
-
Measuring the QT interval on the go. Cardiol J. 2021; 28(3):358-359.
-
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb; 21(1):159-168.
-
COVID-19 and Cardiac Concerns for Psychiatric Patients. Prim Care Companion CNS Disord. 2020 12 03; 22(6).
-
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review. Eur J Clin Invest. 2021 Feb; 51(2):e13428.
-
Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. Ann Saudi Med. 2020 Sep-Oct; 40(5):365-372.
-
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008937.